Results 241 to 250 of about 29,954 (264)

Bruton-Tyrosinkinase-Inhibitor als Frontlinientherapie bei CLL

Im Fokus Onkologie, 2021
openaire   +1 more source

The neuroprotective effect of the GSK-3β inhibitor and influence on the extrinsic apoptosis in the ALS transgenic mice

Journal of the Neurological Sciences, 2012
Kwang-Woo Lee, Jung-Joon Sung, Seung Hyun Kim   +2 more
exaly  

Target‐site mutation accumulation among ALS inhibitor‐resistant Palmer amaranth

Pest Management Science, 2019
Vijay Singh, Muthukumar Bagavathiannan, Nilda Roma-Burgos   +2 more
exaly  

Evolocumab als erster PCSK9-Inhibitor zugelassen

CardioVasc, 2015
openaire   +1 more source

A Small Molecule Screen in Stem-Cell-Derived Motor Neurons Identifies a Kinase Inhibitor as a Candidate Therapeutic for ALS

Cell Stem Cell, 2013
Lance Davidow, Clifford Woolf, Kevin Kim   +2 more
exaly  

Basis of ACCase and ALS inhibitor resistance in Hordeum glaucum Steud

Pest Management Science, 2017
Lovreet Shergill, Gurjeet Gill, Christopher Preston   +2 more
exaly  

Comparison of ALS functionality and plant growth in ALS-inhibitor susceptible and resistant Myosoton aquaticum L.

Pesticide Biochemistry and Physiology, 2017
Jinxin Wang, Weitang Liu
exaly  

Psoriasis – Januskinase-Inhibitor als neue Therapieoption?

Aktuelle Dermatologie, 2016
openaire   +1 more source

Rho-Kinase-Inhibitor bei ALS

InFo Neurologie + Psychiatrie
openaire   +1 more source

Treatment with a Global Methyltransferase Inhibitor Induces the Intranuclear Aggregation of ALS-Linked FUS Mutant In Vitro

Neurochemical Research, 2015
Keiko Kitajo
exaly